Our trusted team of thought leaders provides the latest insights and perspectives on important health industry and management consulting trends and topics.
Following the acquisition of a large company, Vynamic’s global biopharmaceutical client needed to integrate the people, processes, and technology.
Organizational changes at a midsize life sciences company brought together employees from several functions for a newly aligned business.
Read how Vynamic helped our client identify 80+ redundant data deliverables and set up a playbook to optimize future data purchases.
A large biopharmaceutical company sought to boost learning and development for marketing and sales.
The analytics, data, and insights function of a large global pharmaceutical company experienced several substantial changes in a short timeframe.
A second-in-portfolio pharmaceutical product faced underperformance during critical launch window and asked Vynamic to conduct a 360° assessment.
The COVID-19 pandemic has changed how new therapies are commercially launched in the US.
Our Life Sciences client was planning to launch its first Alzheimer’s therapy.
Vynamic conducted a gap analysis of the client’s target markets and competitor engagement strategies, assimilating market research insights.
Vynamic interviewed Global, Regional, and Affiliates in order to identify critical drivers, barriers, and attitudes towards lifecycle management.
Vynamic conducted in-depth surveys to identify institutional, attitudinal, and functional preferences to enable multiple potential segmentation.
Vynamic worked hand-in-hand with the client to transform the ways of working for each therapeutic area.
